Company Filing History:
Years Active: 2020
Title: Ruyi Jin - Innovator in Tubulin Inhibition
Introduction
Ruyi Jin is a notable inventor based in Guangdong, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of tubulin inhibitors. His innovative work has the potential to impact various therapeutic applications.
Latest Patents
Ruyi Jin holds a patent for a new tubulin inhibitor. This invention involves a series of compounds based on substituted heterocyclic skeletons, specifically targeting the colchicine binding sites of tubulin. The patent describes the structure as Formula (I), where the variable 'n' can independently express an integer between 0 and 5, with specific conditions. The groups represented in the formula include a variety of functional groups such as amide, acyloxy, alkanoyl, and others, showcasing the complexity and versatility of his invention.
Career Highlights
Ruyi Jin is affiliated with the Shenzhen Neptunus Pharmaceutical Research Institute Co., Ltd. His work at this institute has allowed him to focus on innovative drug development, particularly in the area of cancer treatment through tubulin inhibition. His research is characterized by a commitment to advancing medical science and improving patient outcomes.
Collaborations
Ruyi Jin collaborates with esteemed colleagues such as Tian Tang and Yanqing Wang. Their combined expertise enhances the research efforts at the Shenzhen Neptunus Pharmaceutical Research Institute, fostering an environment of innovation and discovery.
Conclusion
Ruyi Jin's contributions to the field of tubulin inhibitors exemplify the importance of innovation in pharmaceutical research. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.